Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acella Pharmaceuticals LLC

www.acellapharma.com

Latest From Grail Inc.

M&A Analysis: Grail's Chinese Merger Wraps Up Busy May

It was a robust month for medtech M&A deal making with 17 deals in May, making it the busiest month of the year to date. The total number of acquisitions beat the number recorded in May last year and picked up slightly from the 14 deals inked in the previous month.

M & A Deals

Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017

Medtech companies brought in $2.3 billion in financing in Q1 2017, a slight decrease from Q4 2016; device M&A deals totaled $5.8 billion, a sharp decline from the prior quarter, but there were some billion-dollar deals. Q1 diagnostics financings – totaling $1.2 billion (thanks to a $900 million Series B round by cancer diagnostics company Grail) – showed a significant increase over the preceding quarter, as did the Q1 M&As at $700 million versus the previous $87 million.

Medical Device In Vitro Diagnostics

Execs On The Move, May 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments BioPharmaceutical

VC Deals Analysis: Variety In Volume, But Lackluster Value In April

It would have been difficult to beat March's unusual bumper harvest, which benefitted from Grail's near-$1bn round, but venture fundraising efforts in April were stymied by the absence of deals beyond the $50m mark.

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Gynecological, Urological
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acella Pharmaceuticals LLC
  • Senior Management
  • Harold Deas, Jr., CEO & COO
    Jeff Bryant, Dir., Bus. Dev.
    Allen Fields, VP, Head, R&D
    Tom Larkin, VP, Sales & Mktg.
  • Contact Info
  • Acella Pharmaceuticals LLC
    Phone: (678) 325-5189
    9005 Westside Pkwy.
    Alpharetta, GA 30009-4783
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register